This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Rom E Eliaz: Innovator in Parenteral Formulations
Introduction
Rom E Eliaz is a notable inventor based in Kadima, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of parenteral formulations. His work focuses on enhancing the therapeutic efficacy of medications through innovative delivery methods.
Latest Patents
Rom E Eliaz holds 1 patent for his invention titled "Parenteral formulations of rasagiline." This patent provides a method for preferentially inhibiting monoamine oxidase A (MAOA) in the brain relative to the intestine. The method involves parenterally administering a controlled release formulation containing a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
Career Highlights
Rom E Eliaz is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to contribute to the advancement of drug formulations that improve patient outcomes.
Collaborations
Some of his notable coworkers include Cheryl Fitzer-Attas and Eran Blaugrund, who have collaborated with him on various projects within the pharmaceutical sector.
Conclusion
Rom E Eliaz's innovative work in parenteral formulations exemplifies the impact of targeted drug delivery systems in modern medicine. His contributions continue to influence the pharmaceutical industry and improve therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile